FUNCTIONAL ANTAGONISTIC ACTIVITY OF REC-15 2739, A NOVEL ALPHA-1 ANTAGONIST SELECTIVE FOR THE LOWER URINARY-TRACT, ON NORADRENALINE-INDUCEDCONTRACTION OF HUMAN PROSTATE AND MESENTERIC-ARTERY/
R. Testa et al., FUNCTIONAL ANTAGONISTIC ACTIVITY OF REC-15 2739, A NOVEL ALPHA-1 ANTAGONIST SELECTIVE FOR THE LOWER URINARY-TRACT, ON NORADRENALINE-INDUCEDCONTRACTION OF HUMAN PROSTATE AND MESENTERIC-ARTERY/, The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1237-1246
The aim of this study was to compare with known reference standards th
e functional in vitro alpha-1 antagonistic activity of Rec 15/2739 on
noradrenaline-induced contractions of human prostate and mesenteric ar
tery. We also characterized these tissues with regard to the alpha-1 a
drenoceptor subtypes present. Comparing the apparent pK(B) values reve
aled Rec 15/2739 to be one of the most potent compounds acting on the
prostate. Its potency was slightly lower than that of tamsulosin and w
as higher than the potencies of prazosin, terazosin and 5-methylurapid
il. On the mesenteric artery, tamsulosin was the most potent compound.
Comparing the results from the functional studies with those obtained
from radioreceptor binding studies, we found that the potency (pK(B)
value) in inhibiting the contraction of prostatic tissue showed a clos
e and significant correlation with the affinity for native and recombi
nant alpha-1A adrenoceptors. No significant correlation was found with
affinity for either the native or the recombinant alpha-1B adrenocept
or subtype, or for recombinant alpha-1d receptors. Similar results wer
e obtained for mesenteric artery. In order to characterize further the
alpha-1 adrenoceptor subtypes present in the examined tissues, we inv
estigated the functional effects of chloroethylclonidine, an alpha-1B-
D subtypes selective alpha-1 adrenoceptor irreversible antagonist, and
those of nifedipine, which antagonizes the extracellular calcium infl
ux primarily mediated by alpha-1A adrenoceptor stimulation. The result
s indicate the presence of both chloroethylclonidine-sensitive and -in
sensitive alpha-1 adrenoceptor subtypes in the human prostate, whereas
in mesenteric artery the alpha-1A subtype seems to be present exclusi
vely. The possibility that the functionally relevant alpha-1 adrenocep
tor subtype could be classified as alpha-1 L in both tissues should al
so be considered.